Global Preparative and Process Chromatography Market Size 2020, By Type (Preparative, Process) End Use (Food And Nutraceutical Industry, Biotechnology And Pharmaceutical Industry, Academic Research Laboratories) Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) and Forecast 2021 to 2028
Oct 2020
Total Pages: 100
Choose License Type
The global preparative and process chromatography market was valued at USD 6.76 billion in 2020 and is projected to grow at a CAGR of 6.2% during the forecast period. Factors driving the growth of the preparative and process chromatography market include growing demand for biopharmaceutical products, technology invention and presence of contemporary technologies for chromatographic instruments.
The global preparative and process chromatography market is segmented based on type and end use. On the basis of type, the market is segmented into preparative and process chromatography. The process chromatography was the largest market in 2019. By end use, the market is segmented into food and nutraceutical industry, biotechnology and pharmaceutical industry, and academic research laboratories. The biotechnology and pharmaceutical industry segment accounted for the largest share of the global preparative and process chromatography market and is projected to sustain its dominance over the forecast period.
Regionally, North America accounted for the largest market share of the global preparative and process chromatography market attributable to increasing healthcare set-up. Leading players of the global preparative and process chromatography market include GE Healthcare, Merck KGaA, Pall Corporation, Bio-Rad Laboratories, Shimadzu Corporation, Chiral Technologies, Inc., Thermo Fisher Scientific Inc., Waters Corporation, Agilent Technologies, Novasep Holding S.A.S among others.
Key segments of the global preparative and process chromatography market
Type Overview, 2018-2028 (USD Billion)
- Preparative Chromatography
- Process Chromatography
End-use Overview, 2018-2028 (USD Billion)
- Biotechnology & Pharmaceutical Industry
- Food & Nutraceutical Industry
- Academic Research Laboratories
Regional Overview, 2018-2028 (USD Billion)
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- GCC
- South Africa
Reasons for the study
- Increasing investments by the government to enhance R&D
- Growing use of chromatography techniques in the food and nutraceutical industry
- Growing demand for biopharmaceutical products
What does the report include?
- The study on the global preparative and process chromatography market includes qualitative factors such as drivers, restraints and opportunities
- The study covers qualitative and quantitative analysis of the market segmented on the basis of type and end use. Moreover, the study provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the above-mentioned segments
- The study includes the profiles of key players in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global preparative and process chromatography market is suitable for all the players across the value chain including product manufacturing companies, suppliers/distributors, R&D labs, CROs, healthcare organizations, medical reimbursement and insurance providers
- Venture capitalists and investors looking for more information on the future outlook of the global preparative and process chromatography market
Consultants, analysts, researchers, and academicians looking for insights shaping the global preparative and process chromatography
Biopharmaceutical producers initially focused on the quest for better production titers. As a result, the productivity bottleneck shifted from upstream to downstream processing. With the support of the US Food and Drug Administration (FDA) and other regulatory bodies, industrial players are now looking for more integrated approaches to develop high-performance processes in a competitive and pressurized environment. A particular driver for more cost-effective processes is biosimilar and bio better production. Chromatography remains the workhorse of modern biologics purification processes, with typically at least two orthogonal chromatography steps allowing purity (of greater than 99 per cent) to be reached. Depending on the product (small molecules or large biologics) and process characteristics, the technology can be operated under low or high pressure with chiral, reverse-phase, affinity or ion exchange media.
The preparative chromatography is expected to grow at a highest CAGR by 2028. Preparative chromatography is a novel technique that can be applied as a pre-cursor to efficiently determine the structures of the unknown impurities or purify a sample to meet specification. Dealing with these unknown impurities, for example in finished products, stability samples or discovery compounds, can be very challenging as failure to identify or remove them might interrupt product supply, delay clinical studies or interfere with toxicology studies. Very often there is a regulatory requirement to disclose structure of new impurities above a certain limit. The financial loss to the pharmaceutical, agrochemical, food and consumer goods and fine chemical industry can be enormous.
North America dominated the market for preparative and process chromatography in 2019. Among U.S. industries, the biopharmaceutical industry stands out as a leader in innovation-led development. The comparative data can be striking. For example, the Brookings Institution in its report on advanced industries found that the biopharmaceutical industry has the highest R&D spending per worker far exceeding the next highest industry, communications equipment, by more than 57%. The biopharmaceutical industry invests more than USD114,000 per employee in R&D, the largest among key U.S. industrial sectors. This figure is more than six times larger than the R&D per employee average for all U.S. industries and more than four times larger than the manufacturing sector as a whole. All these factors are expected to propel the preparative and process chromatography market in this region.
The global preparative and process chromatography market was valued at USD 6.76 billion in 2020 and is projected to grow at a CAGR of 6.2% during the forecast period. Factors driving the growth of the preparative and process chromatography market include growing demand for biopharmaceutical products, technology invention and presence of contemporary technologies for chromatographic instruments.
The global preparative and process chromatography market is segmented based on type and end use. On the basis of type, the market is segmented into preparative and process chromatography. The process chromatography was the largest market in 2019. By end use, the market is segmented into food and nutraceutical industry, biotechnology and pharmaceutical industry, and academic research laboratories. The biotechnology and pharmaceutical industry segment accounted for the largest share of the global preparative and process chromatography market and is projected to sustain its dominance over the forecast period.
Regionally, North America accounted for the largest market share of the global preparative and process chromatography market attributable to increasing healthcare set-up. Leading players of the global preparative and process chromatography market include GE Healthcare, Merck KGaA, Pall Corporation, Bio-Rad Laboratories, Shimadzu Corporation, Chiral Technologies, Inc., Thermo Fisher Scientific Inc., Waters Corporation, Agilent Technologies, Novasep Holding S.A.S among others.
Key segments of the global preparative and process chromatography market
Type Overview, 2018-2028 (USD Billion)
- Preparative Chromatography
- Process Chromatography
End-use Overview, 2018-2028 (USD Billion)
- Biotechnology & Pharmaceutical Industry
- Food & Nutraceutical Industry
- Academic Research Laboratories
Regional Overview, 2018-2028 (USD Billion)
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- GCC
- South Africa
Reasons for the study
- Increasing investments by the government to enhance R&D
- Growing use of chromatography techniques in the food and nutraceutical industry
- Growing demand for biopharmaceutical products
What does the report include?
- The study on the global preparative and process chromatography market includes qualitative factors such as drivers, restraints and opportunities
- The study covers qualitative and quantitative analysis of the market segmented on the basis of type and end use. Moreover, the study provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the above-mentioned segments
- The study includes the profiles of key players in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global preparative and process chromatography market is suitable for all the players across the value chain including product manufacturing companies, suppliers/distributors, R&D labs, CROs, healthcare organizations, medical reimbursement and insurance providers
- Venture capitalists and investors looking for more information on the future outlook of the global preparative and process chromatography market
Consultants, analysts, researchers, and academicians looking for insights shaping the global preparative and process chromatography
1. Introduction
1.1. Introduction to the Study
1.2. Market Definition and Scope
1.3. Units, Currency, Conversions and Years Considered
1.4. Key Stakeholders
1.5. Key Questions Answered
2. Research Methodology
2.1. Introduction
2.2. Data Capture Sources
2.2.1. Primary Sources
2.2.2. Secondary Sources
2.3. Market Size Estimation
2.4. Market Forecast
2.5. Data Triangulation
2.6. Assumptions and Limitations
3. Executive Summary
4. Market Outlook
4.1. Introduction
4.2. Market dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porter’s five forces analysis
4.4. Value chain analysis
4.5. COVID-19 impact analysis
5. Preparative and Process Chromatography Market by Type, 2018-2028 (USD Billion)
5.1. Introduction
5.2. Preparative
5.3. Process
6. Preparative and Process Chromatography Market by End use, 2018-2028 (USD Billion)
6.1. Introduction
6.2. Food & nutraceutical industry
6.3. Biotechnology & pharmaceutical industry
6.4. Academic research laboratories
7. Preparative and Process Chromatography Market by Region, 2018-2028 (USD Billion)
7.1. North America
7.1.1. U.S.
7.1.2. Canada
7.2. Europe
7.2.1. UK
7.2.2. France
7.2.3. Germany
7.2.4. Rest of Europe
7.3. Asia Pacific
7.3.1. China
7.3.2. Japan
7.3.3. India
7.3.4. Rest of Asia Pacific
7.4. South America
7.4.1. Brazil
7.4.2. Mexico
7.4.3. Rest of South America
7.5. Middle East and Africa
7.5.1. GCC
7.5.2. South Africa
7.5.3. Rest of Middle East & Africa
8. Competitive Landscape
8.1. Introduction
8.2. Strategic initiatives
8.2.1. Mergers & acquisitions
8.2.2. New product launch
8.2.3. Investments
8.2.4. Expansion
8.2.5. Others
9. Company Profiles
(Overview, Products and Services Portfolio, Recent Initiatives, Company Financials)
9.1. GE Healthcare
9.2. Merck KGaA
9.3. Pall Corporation
9.4. Bio-Rad Laboratories
9.5. Shimadzu Corporation
9.6. Chiral Technologies, Inc.
9.7. Thermo Fisher Scientific Inc.
9.8. Waters Corporation
9.9. Agilent Technologies
9.10. Novasep Holding S.A.S